<DOC>
	<DOCNO>NCT02619526</DOCNO>
	<brief_summary>Heart failure ( HF ) common disable condition elderly . Randomized clinical trial meta-analyses clearly demonstrate long-term use β blocker improve outcome patient HF . However , limited data available treatment HF preserve ejection fraction ( EF ) elderly . No study specifically compare relative effectiveness carvedilol nebivolol treat HF old age patient preserve EF .</brief_summary>
	<brief_title>Comparative Effects Nebivolol Carvedilol Diastolic Function Elderly Heart Failure Patients</brief_title>
	<detailed_description>This trial prospective , randomize , open-label , active control study design investigate effect nebivolol carvedilol diastolic function leave ventricle ( LV ) elderly HF patient preserve EF . Patients include study LVEF ≥ 40 % , NYHA functional class I , II III , clinical stability without hospital admission HF precede 3 month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>70 year EF ≥ 40 % contraindication study drug</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>